10 results
POCUS Lung Algorithm for the Use of Ultrasound in the Evaluation of Dyspnea 

#Diagnosis #Management #CriticalCare
POCUS Lung Algorithm ... #Diagnosis #Management ... #CriticalCare #POCUS ... #Dyspnea #Algorithm ... #Ddxof #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
B profile is a half ... , a half B-profile ... BLUE #protocol #Algorithm ... #CriticalCare #POCUS ... #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
with lung-rockets ... B profile is a half ... A-profile at one lung ... , a half B-profile ... dyspnea-criticalcare-pulmonary-algorithm-pocus
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
B profile is a half ... , a half B-profile ... BLUE #protocol #Algorithm ... #CriticalCare #POCUS ... #Lung #Pulmonary
Hyperacute Hypoxemia - Workup and Management
Differential Diagnosis: Aspiration, Flash Pulmonary Edema, Mucous Plugging, Bronchospasm, Pulmonary Embolism,
Bronchospasm, Pulmonary ... (JVP, edema), Lung ... Exam, POCUS (B-lines ... , lung sliding) ... stacked nebs • PE: anticoagulation
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... thrombosis; PE = pulmonary ... Malignancy #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
Spontaneous • Calf ... post-thrombotic syndrome ... Bloodman #VTE #anticoagulation ... #duration #management ... #DVT #hematology
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
Amiodarone Induced Lung ... Direct cytotoxic lung ... • Amiodarone half ... respiratory distress syndrome ... #diagnosis #management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... Anticoagulation ... unless prior heart/lung ... medical and surgical management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
JAK2, CALR-calreticulin ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology